Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Biopharmaceutical Study of Inclusion Complexes. I. Pharmaceutical Advantages of Cyclodextrin Complexes of Bencyclane Fumarate
KEIJI FUJIOKAYUJI KUROSAKISHIGEJI SATOTETSUO NOGUCHITAKESHI NOGUCHIYOSHIYA YAMAHIRA
Author information
Keywords: bitterness
JOURNAL FREE ACCESS

1983 Volume 31 Issue 7 Pages 2416-2423

Details
Abstract

Complexes of bencyclane fumarate (Ben) with cyclodextrins (CDs) were newly prepared and their characteristics were studied from a pharmaceutical viewpoint. The results of differential scanning calorimetry (DSC), X-ray diffractometry and thin-layer chromatography (TLC) were consistent with the formation of inclusion complexes. Water solubility of Ben-CDs were 2- to 8-fold lager than that of Ben. The stability of Ben in acidic media (pH 1.2) was considerably improved by complex formation with β-CD or γ-CD. Apparent first-order rate constants [h-1] of hydrolysis of Ben were 6.5×10-2, 5.5×10-2, 1.0×10-2 and 1.7×10-2 for Ben, Ben-α-CD, Ben-β-CD and Ben-γ-CD, respectively. The intrinsic bitter taste of Ben was significantly reduced by inclusion complexation with CDs. Thus, there are clear pharmaceutical advantages of Ben-CD compared with Ben. In addition, a novel animal test method, which is helpful for studying astringent bitter-tasting drugs, is proposed.

Content from these authors
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top